Works in Cancer Chemotherapy & Pharmacology, 2013, Vol 72, Issue 3

Results: 26

The small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin.

Published in:

2013

By:

Shaw, Jiajiu;
Media, Joseph;
Chen, Ben;
Valeriote, Fredrick

Publication type:

journal article

Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids.

Published in:

2013

By:

Sun, Susan;
Schaller, Joseph;
Placek, Jiri;
Duersch, Brett

Publication type:

journal article

Effects of β-lapachone, a new anticancer candidate, on cytochrome P450-mediated drug metabolism.

Published in:

2013

By:

Kim, In Sook;
Kim, Yun;
Kwak, Tae Hwan;
Yoo, Hye Hyun

Publication type:

journal article

Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 515, doi. 10.1007/s00280-013-2214-x

By:

Sémiond, D.;
Sidhu, S.;
Bissery, M.-C.;
Vrignaud, P.

Publication type:

Article

Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 493, doi. 10.1007/s00280-013-2220-z

By:

Iwamoto, Marian;
Friedman, Evan;
Sandhu, Punam;
Agrawal, Nancy;
Rubin, Eric;
Wagner, John

Publication type:

Article

Compatibility of intravenous fosaprepitant with intravenous 5-HT antagonists and corticosteroids.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 509, doi. 10.1007/s00280-013-2201-2

By:

Sun, Susan;
Schaller, Joseph;
Placek, Jiri;
Duersch, Brett

Publication type:

Article

The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 597, doi. 10.1007/s00280-013-2231-9

By:

Visentin, Michele;
Unal, Ersin;
Zhao, Rongbao;
Goldman, I.

Publication type:

Article

Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 653, doi. 10.1007/s00280-013-2241-7

By:

Song, Taejong;
Kim, Min;
Lee, Yoo-Young;
Choi, Chel;
Kim, Tae-Joong;
Lee, Jeong-Won;
Kim, Byoung-Gie;
Bae, Duk

Publication type:

Article

Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese patients with advanced colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 643, doi. 10.1007/s00280-013-2240-8

By:

Doi, Toshihiko;
Muro, Kei;
Yoshino, Takayuki;
Fuse, Nozomu;
Ura, Takashi;
Takahari, Daisuke;
Feng, Hwa-ping;
Shimamoto, Takashi;
Noguchi, Kazuo;
Ohtsu, Atsushi

Publication type:

Article

Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 565, doi. 10.1007/s00280-013-2227-5

By:

Yoo, Changhoon;
Yun, Mi;
Ahn, Jin-Hee;
Jung, Kyung;
Kim, Hwa;
Kim, Jeong;
Park, Jeong;
Park, Kwang;
Yoon, Dok;
Kim, Sung-Bae

Publication type:

Article

A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 537, doi. 10.1007/s00280-013-2224-8

By:

Rathkopf, Dana;
Picus, Joel;
Hussain, Arif;
Ellard, Susan;
Chi, Kim;
Nydam, Thomas;
Allen-Freda, Erin;
Mishra, Kaushal;
Porro, Maria;
Scher, Howard;
Wilding, George

Publication type:

Article

Scheduling of paclitaxel and gefitinib to inhibit repopulation for optimal treatment of human cancer cells and xenografts that overexpress the epidermal growth factor receptor.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 585, doi. 10.1007/s00280-013-2229-3

By:

Fung, Andrea;
Yu, Man;
Ye, Qian;
Tannock, Ian

Publication type:

Article

Clinical effects of A4889G and T6235C polymorphisms in cytochrome P-450 CYP1A1 for breast cancer patients treated with tamoxifen: implications for tumor aggressiveness and patient survival.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 529, doi. 10.1007/s00280-013-2221-y

By:

Cardoso-Filho, Cassio;
Sarian, Luis;
Oliveira, Camila;
Silveira Bossi, Leonardo;
Lourenço, Gustavo;
Lima, Carmen;
Gurgel, Maria

Publication type:

Article

Effects of β-lapachone, a new anticancer candidate, on cytochrome P450-mediated drug metabolism.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 699, doi. 10.1007/s00280-013-2230-x

By:

Kim, In;
Kim, Yun;
Kwak, Tae;
Yoo, Hye

Publication type:

Article

The small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 703, doi. 10.1007/s00280-013-2236-4

By:

Shaw, Jiajiu;
Media, Joseph;
Chen, Ben;
Valeriote, Fredrick

Publication type:

Article

CPT-11 as a second-line treatment for patients with advanced/metastatic gastric cancer who failed S-1 (CCOG0702).

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 629, doi. 10.1007/s00280-013-2235-5

By:

Mochizuki, Yoshinari;
Ohashi, Norifumi;
Kojima, Hiroshi;
Ishigure, Kiyoshi;
Kinoshita, Takashi;
Eguchi, Takehiko;
Fujitake, Shinichi;
Ito, Seiji;
Fujiwara, Michitaka;
Kodera, Yasuhiro

Publication type:

Article

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 619, doi. 10.1007/s00280-013-2234-6

By:

Seto, Takashi;
Esaki, Taito;
Hirai, Fumihiko;
Arita, Shuji;
Nosaki, Kaname;
Makiyama, Akitaka;
Kometani, Takuro;
Fujimoto, Chinatsu;
Hamatake, Motoharu;
Takeoka, Hiroaki;
Agbo, Felix;
Shi, Xiaojin

Publication type:

Article

Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 553, doi. 10.1007/s00280-013-2226-6

By:

Hamed, Salaheldin;
Straubinger, Robert;
Jusko, William

Publication type:

Article

Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 683, doi. 10.1007/s00280-013-2247-1

By:

Podolski-Renić, Ana;
Jadranin, Milka;
Stanković, Tijana;
Banković, Jasna;
Stojković, Sonja;
Chiourea, Maria;
Aljančić, Ivana;
Vajs, Vlatka;
Tešević, Vele;
Ruždijić, Sabera;
Gagos, Sarantis;
Tanić, Nikola;
Pešić, Milica

Publication type:

Article

The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 669, doi. 10.1007/s00280-013-2246-2

By:

Mohelnikova-Duchonova, Beatrice;
Brynychova, Veronika;
Hlavac, Viktor;
Kocik, Matej;
Oliverius, Martin;
Hlavsa, Jan;
Honsova, Eva;
Mazanec, Jan;
Kala, Zdenek;
Melichar, Bohuslav;
Soucek, Pavel

Publication type:

Article

A phase II study of intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 545, doi. 10.1007/s00280-013-2225-7

By:

Rao, Krishna;
Kalapurakal, Sini;
Chalasani, Pratima;
Robinson, Kathy;
Malone, James;
Clausen, Cathy;
Ronen, Ohad;
Dhiwakar, Muthuswamy;
Shevlin, Bruce;
Robbins, K.

Publication type:

Article

A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 607, doi. 10.1007/s00280-013-2232-8

By:

Bemer, Meagan;
Sorror, Mohamed;
Sandmaier, Brenda;
O'Donnell, Paul;
McCune, Jeannine

Publication type:

Article

Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 709, doi. 10.1007/s00280-013-2243-5

By:

Goldschmidt, Neta;
Gural, Alexander;
Ben-Yehuda, Dina;
Gatt, Moshe

Publication type:

Article

A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 637, doi. 10.1007/s00280-013-2239-1

By:

Chao, Yee;
Wu, Chen-Yi;
Wang, Jack;
Lee, Rheun-Chuan;
Lee, Wei-Ping;
Li, Chung-Pin

Publication type:

Article

Phase I and pharmacokinetic/pharmacodynamic study of RO5126766, a first-in-class dual Raf/MEK inhibitor, in Japanese patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 577, doi. 10.1007/s00280-013-2228-4

By:

Honda, Kazunori;
Yamamoto, Noboru;
Nokihara, Hiroshi;
Tamura, Yosuke;
Asahina, Hajime;
Yamada, Yasuhide;
Suzuki, Shigenobu;
Yamazaki, Naoya;
Ogita, Yoshitaka;
Tamura, Tomohide

Publication type:

Article

Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genes.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 661, doi. 10.1007/s00280-013-2242-6

By:

Kolesar, Jill;
Traynor, Anne;
Holen, Kyle;
Hoang, Tien;
Seo, Songwon;
Kim, KyungMann;
Alberti, Dona;
Espinoza-Delgado, Igor;
Wright, John;
Wilding, George;
Bailey, Howard;
Schelman, William

Publication type:

Article